Burian Aura, Wang Kevin L, Finton Kathryn A K, Lee Ni, Ishitani Akiko, Strong Roland K, Geraghty Daniel E
The Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109, United States of America.
The Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109, United States of America.
PLoS One. 2016 Sep 20;11(9):e0163297. doi: 10.1371/journal.pone.0163297. eCollection 2016.
Based on previous findings supporting HLA-F as a ligand for KIR3DL2 and KIR2DS4, we investigated the potential for MHC-I open conformers (OCs) as ligands for KIR3DS1 and KIR3DL1 through interactions measured by surface plasmon resonance. These measurements showed physical binding of KIR3DS1 but not KIR3DL1 with HLA-F and other MHC-I OC while also confirming the allotype specific binding of KIR3DL1 with MHC-I peptide complex. Concordant results were obtained with biochemical pull-down from cell lines and biochemical heterodimerization experiments with recombinant proteins. In addition, surface binding of HLA-F and KIR3DS1 to native and activated NK and T cells was coincident with specific expression of the putative ligand or receptor. A functional response of KIR3DS1 was indicated by increased granule exocytosis in activated cells incubated with HLA-F bound to surfaces. The data extend a model for interaction between MHC-I open conformers and activating KIR receptors expressed during an inflammatory response, potentially contributing to communication between the innate and adaptive immune response.
基于先前支持HLA - F作为KIR3DL2和KIR2DS4配体的研究结果,我们通过表面等离子体共振测量的相互作用,研究了MHC - I开放构象体(OCs)作为KIR3DS1和KIR3DL1配体的可能性。这些测量结果显示,KIR3DS1与HLA - F和其他MHC - I OC存在物理结合,而KIR3DL1则不然,同时也证实了KIR3DL1与MHC - I肽复合物的同种异型特异性结合。从细胞系进行生化下拉实验以及用重组蛋白进行生化异源二聚化实验也得到了一致的结果。此外,HLA - F和KIR3DS1与天然和活化的NK细胞及T细胞的表面结合与推定配体或受体的特异性表达一致。与结合在表面的HLA - F一起孵育的活化细胞中颗粒胞吐作用增加,表明KIR3DS1有功能反应。这些数据扩展了炎症反应期间表达的MHC - I开放构象体与活化KIR受体之间相互作用的模型,可能有助于先天免疫反应和适应性免疫反应之间的交流。